Caspr5-2 Inhibitors
Cntnap5b, a gene predicted to act upstream of or within cell adhesion, exhibits a pivotal role in cellular interactions by virtue of its integral presence in the membrane. This protein, expressed in the brain and spinal cord, shares orthology with the human counterpart CNTNAP5. Functionally, Cntnap5b is deeply involved in the maintenance of cell adhesion processes. Its predicted position as an integral component of the membrane emphasizes its significance in mediating cellular interactions and highlights its potential impact on membrane-associated events.
Inhibition of Cntnap5b involves a comprehensive approach targeting various cellular processes critical for its function. Actin cytoskeleton dynamics, integral to cell adhesion, are directly affected by certain inhibitors, disrupting the intricate balance required for Cntnap5b to fulfill its role in cellular interactions. Additionally, compounds influencing vesicular trafficking and integrin-mediated processes exhibit indirect effects on Cntnap5b, indicating the complexity of the pathways intertwined with its function. The modulation of these diverse cellular mechanisms underscores the versatility in inhibiting Cntnap5b, providing researchers with an array of tools to investigate its intricate involvement in cell adhesion. The integration of these inhibitors into studies on Cntnap5b promises to unravel deeper insights into the regulation of cellular interactions and the potential implications for various physiological processes within the brain and spinal cord.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Latrunculin A, Latrunculia magnifica | 76343-93-6 | sc-202691 sc-202691B | 100 µg 500 µg | $265.00 $815.00 | 36 | |
Latrunculin A, an actin polymerization inhibitor, directly disrupts cell adhesion by interfering with actin cytoskeleton dynamics, impacting the function of Cntnap5b in regulating cellular interactions. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Brefeldin A, a vesicular trafficking inhibitor, indirectly inhibits Cntnap5b by disrupting membrane-associated processes, influencing the integral membrane component functions of Cntnap5b in cell adhesion. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632, a ROCK inhibitor, indirectly affects Cntnap5b by modulating actin cytoskeleton dynamics. By inhibiting ROCK, this compound influences downstream events associated with Cntnap5b's role in cell adhesion. | ||||||
Tirofiban-d6 | 144494-65-5 (unlabeled) | sc-475655 | 1 mg | $450.00 | ||
Tirofiban, an integrin antagonist, directly inhibits cell adhesion by blocking integrin functions. By disrupting integrin-mediated processes, this compound influences Cntnap5b's role in maintaining cellular interactions. | ||||||
Dynamin Inhibitor I, Dynasore | 304448-55-3 | sc-202592 | 10 mg | $89.00 | 44 | |
Dynasore, a dynamin inhibitor, indirectly inhibits Cntnap5b by disrupting vesicular trafficking. By inhibiting dynamin, this compound impacts membrane-associated processes related to Cntnap5b's function. | ||||||
Taxol | 33069-62-4 | sc-201439D sc-201439 sc-201439A sc-201439E sc-201439B sc-201439C | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $41.00 $74.00 $221.00 $247.00 $738.00 $1220.00 | 39 | |
Taxol, a microtubule-targeting agent, directly influences cell adhesion processes. By stabilizing microtubules, this compound affects downstream events associated with Cntnap5b's role in maintaining cellular interactions. | ||||||
XAV939 | 284028-89-3 | sc-296704 sc-296704A sc-296704B | 1 mg 5 mg 50 mg | $36.00 $117.00 $525.00 | 26 | |
XAV939, a Wnt signaling antagonist, indirectly impacts Cntnap5b by modulating cell adhesion-related signaling pathways. By inhibiting Wnt signaling, this compound influences downstream events related to Cntnap5b. | ||||||